Buparlisib is a brain penetrable pan-PI3K inhibitor

Mark C. de Gooijer(Manchester Academic Health Science Centre), Olaf van Tellingen(Oncode Institute)
Scientific Reports
July 11, 2018
Cited by 80


Related Papers